The role of estrogen supplementation in lower urinary tract dysfunction

Area of Science:

• Gynecology
• Urology
• Endocrinology

Background:

• The female lower urinary and genital tracts share developmental origins from the urogenital sinus.
• Sex hormones, especially estrogen, significantly impact the female lower urinary tract throughout adulthood.
• Hormonal fluctuations during the menstrual cycle, pregnancy, and menopause can lead to urogenital changes and symptoms.

Purpose of the Study:

• To explore the influence of sex hormones on the female lower urinary tract.
• To review the effects of estrogen deficiency and supplementation on urogenital complaints.
• To assess the efficacy of hormone replacement therapy for menopausal urinary symptoms and recurrent urinary tract infections.

Main Methods:

• Review of existing literature on female lower urinary tract function and hormonal influences.
• Analysis of studies investigating estrogen therapy for urinary incontinence and other urogenital symptoms.
• Examination of evidence regarding hormone replacement therapy for postmenopausal urinary issues.

Main Results:

• Estrogen deficiency is linked to urinary frequency, nocturia, incontinence, urinary tract infections, and urge syndrome.
• Estrogen supplementation shows subjective improvement in stress urinary incontinence, with combined therapy (estrogen and phenylpropanolamine) potentially more effective.
• Hormone replacement therapy may alleviate postmenopausal irritative urinary symptoms by addressing urogenital atrophy and potentially preventing recurrent urinary tract infections.

Conclusions:

• Estrogen plays a critical role in maintaining the health and function of the female lower urinary tract.
• Estrogen therapy offers potential benefits for menopausal urinary symptoms and recurrent urinary tract infections.
• Further research is needed to determine the optimal type, route, and duration of estrogen therapy for urogenital health.